Jesus G. Valenzuela
Affiliations: | Biomedical Sciences | The George Washington University, Washington, DC, United States |
Area:
Parasitology Biology, Microbiology Biology, Molecular BiologyGoogle:
"Jesus Valenzuela"Children
Sign in to add trainee| Mariel Gindin | grad student | 2012 | The George Washington University |
| Joshua R. Lacsina | post-doc | 2017- | (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Abdeladhim M, Teixeira C, Ressner R, et al. (2025) salivary proteins elicit human innate and adaptive immune responses detrimental to parasites. Biorxiv : the Preprint Server For Biology |
| Costa GCA, Ribeiro ICT, Giunchetti RC, et al. (2024) Gut membrane proteins as candidate antigens for immunization of mice against the tick Amblyomma sculptum. Vaccine. 126141 |
| de Araujo FF, Abdeladhim M, Teixeira C, et al. (2024) Immune response profiles from humans experimentally exposed to bites. Frontiers in Immunology. 15: 1335307 |
| Souissi C, Marzouki S, Elbini-Dhouib I, et al. (2023) PpSP32, the Phlebotomus papatasi immunodominant salivary protein, exerts immunomodulatory effects on human monocytes, macrophages, and lymphocytes. Parasites & Vectors. 16: 1 |
| Karmakar S, Volpedo G, Zhang WW, et al. (2022) Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis. Npj Vaccines. 7: 157 |
| Friedman-Klabanoff DJ, Birkhold M, Short MT, et al. (2022) Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial. Ebiomedicine. 86: 104375 |
| Guerrero D, Vo HTM, Lon C, et al. (2022) Evaluation of cutaneous immune response in a controlled human in vivo model of mosquito bites. Nature Communications. 13: 7036 |
| Aoki V, Abdeladhim M, Li N, et al. (2022) Some Good and Some Bad: Sand Fly Salivary Proteins in the Control of Leishmaniasis and in Autoimmunity. Frontiers in Cellular and Infection Microbiology. 12: 839932 |
| Matias J, Kurokawa C, Sajid A, et al. (2021) Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies. Vaccine. 39: 7661-7668 |
| Karmakar S, Ismail N, Oliveira F, et al. (2021) Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis. Communications Biology. 4: 929 |